Skip to main content
. 2022 Jun 13;2022(6):CD013030. doi: 10.1002/14651858.CD013030.pub2

Sportel 2020.

Methods Randomised controlled trial lasting 6 weeks
Participants 68 uncontrolled moderate to severe asthmatic children between 6 and 18 years old who receive controller inhalation medication through the Nexthaler(R), Ellipta(R), or Spiromax(R)
Interventions Immediate smart feedback about the performed inhalations via a mobile application
Outcomes Asthma control can be assessed by means of spirometry (both at home and in the hospital) and (c‐)ACT questionnaires
Notes